{"title":"Complementary Treatment in Pain Reduction and Improving Functional Capacity at Elderly with Osteoarthritis","link":"https://www.preprints.org/manuscript/202410.1533/v1","date":1729494332000,"content":"Background and Objectives: A degenerative joint disease that primarily affects the elderly, oste-oarthritis (OA) causes pain, decreased mobility, and a lower quality of life. The effectiveness of GerovitalH3, a biotrophic medication created by Ana Aslan, in reducing pain and enhancing function in older people with osteoarthritis in the knee and hip is assessed in this study. Materials and Methods: Two groups of 201 patients aged 65 and older participated in a randomized, case-control clinical trial. One group received physical therapy and GerovitalH3 periarticular in-jections, while the other group received just physical therapy. In addition to functional evaluations using the Lequesne Index, Activities of Daily Living (ADL), and Instrumental ADL (IADL) scores, pain was assessed using a Visual Analogue Scale (VAS).\nResults: The GerovitalH3 group showed a substantial decrease in pain (p","author":"","siteTitle":"Preprints.org - The Multidisciplinary Preprint Platform","siteHash":"abac34b0506002eba4392ac15186820b9b5d7a0f2e5fce3a3511408258fb1a7e","entryHash":"0ef0a642570f9f6e402e684a9869f2e40737d4f8b0a3043b4c5c92f3ad423122","category":"Interdisciplinary"}